Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 11Unknown 3Recruiting 3Active not recruiting 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 49Rectal Neoplasms 32Pancreatic Neoplasms 28Colonic Neoplasms 24Stomach Neoplasms 19Neoplasm Metastasis 15Neoplasms 13Esophageal Neoplasms 10Breast Neoplasms 7Head and Neck Neoplasms 6Recurrence 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma Of Esophagus 5Lymphoma, Large B-Cell, Diffuse 4Carcinoma, Hepatocellular 4Ovarian Neoplasms 3Lymphoma, Extranodal NK-T-Cell 3Liver Neoplasms 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Fallopian Tube Neoplasms 3Cholangiocarcinoma 3Adenocarcinoma 3Unspecified Adult Solid Tumor, Protocol Specific 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Peritoneal Neoplasms 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Non-Hodgkin 2

Interventions

Cisplatin 8Radiotherapy 7Fluorouracil 6Neoadjuvant Therapy 4Irinotecan 4pembrolizumab 3Paclitaxel 3Gefitinib 3Carboplatin 3toripalimab 2spartalizumab 2Oxaliplatin 2Nivolumab 2Esophagectomy 2Docetaxel 2vandetanib 1tislelizumab 1sitravatinib 1ribociclib 1oblimersen 1nazartinib 1liposomal doxorubicin 1apatinib 1Surgical Procedures, Operative 1SGN-LIV1A 1Proton Therapy 1Pemetrexed 1Panitumumab 1Nutritional Support 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Esophageal Squamous Cell Carcinoma × Oxaliplatin × Clear all
NCT00093652 2015-10-06

Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer

Roswell Park Cancer Institute

Phase 1/2 Terminated
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00732745 2011-08-22

Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction

Case Comprehensive Cancer Center

Phase 1 Terminated
9 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡